Morgan Stanley Maintains Overweight on Exelon, Lowers Price Target to $47
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst David Arcaro maintains an Overweight rating on Exelon (NASDAQ:EXC) and lowers the price target from $48 to $47.
June 23, 2023 | 1:31 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley maintains an Overweight rating on Exelon and lowers the price target from $48 to $47.
Morgan Stanley's lowered price target on Exelon may have a neutral short-term impact on the stock price. While the Overweight rating indicates a positive outlook, the reduced price target may offset any potential gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100